IS2407A7 - Aðferð til þess að framleiða blóðþrýstingslækkandi lyf. - Google Patents
Aðferð til þess að framleiða blóðþrýstingslækkandi lyf.Info
- Publication number
- IS2407A7 IS2407A7 IS2407A IS2407A IS2407A7 IS 2407 A7 IS2407 A7 IS 2407A7 IS 2407 A IS2407 A IS 2407A IS 2407 A IS2407 A IS 2407A IS 2407 A7 IS2407 A7 IS 2407A7
- Authority
- IS
- Iceland
- Prior art keywords
- antihypertensive drugs
- producing antihypertensive
- producing
- drugs
- antihypertensive
- Prior art date
Links
- 239000002220 antihypertensive agent Substances 0.000 title 1
- 229940127088 antihypertensive drug Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/04—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having less than three double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/08—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/12—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/20—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/725,597 US4230705A (en) | 1976-09-22 | 1976-09-22 | 6-Phenyl-1,2,4-triazolo[4,3-b]pyridazines and their uses in treating anxiety |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS2407A7 true IS2407A7 (is) | 1977-10-05 |
Family
ID=24915205
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS2407A IS2407A7 (is) | 1976-09-22 | 1977-09-01 | Aðferð til þess að framleiða blóðþrýstingslækkandi lyf. |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US4230705A (is) |
| BE (1) | BE858949A (is) |
| IS (1) | IS2407A7 (is) |
| MC (1) | MC1168A1 (is) |
| MW (1) | MW2177A1 (is) |
| PH (1) | PH13960A (is) |
| SE (1) | SE7710595L (is) |
| SU (1) | SU793399A3 (is) |
| ZA (1) | ZA775110B (is) |
| ZM (1) | ZM6677A1 (is) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2562071B1 (fr) * | 1984-03-30 | 1986-12-19 | Sanofi Sa | Triazolo(4,3-b)pyridazines, procede pour leur preparation et compositions pharmaceutiques les contenant |
| US4569934A (en) * | 1984-10-09 | 1986-02-11 | American Cyanamid Company | Imidazo[1,2-b]pyridazines |
| US4591589A (en) * | 1985-01-16 | 1986-05-27 | Roussel Uclaf | 2-aryl pyrazolo[4,3-c]cinnolin-3-ones |
| US4654343A (en) * | 1985-10-31 | 1987-03-31 | American Cyanamid Company | N-substituted-N[3-(1,2,4-triazolo[4,3-b]pyridazin-6-yl)phenyl]alkanamides, carbamates and ureas |
| GB9726702D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
| GB9723999D0 (en) | 1997-11-13 | 1998-01-14 | Merck Sharp & Dohme | Therapeutic use |
| GB9726701D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
| GB9726699D0 (en) * | 1997-12-18 | 1998-02-18 | Merck Sharp & Dohme | Therapeutic use |
| US6110915A (en) * | 1997-12-18 | 2000-08-29 | Merck & Co., Inc. | Antiemetic use of triazolo-pyridazine derivatives |
| WO1999036423A1 (en) | 1998-01-14 | 1999-07-22 | Merck Sharp & Dohme Limited | Triazolo-pyridazine derivatives as ligands for gaba receptors |
| GB9801202D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801210D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801234D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| CZ290883B6 (cs) * | 1998-01-21 | 2002-11-13 | Merck Sharp And Dohme Limited | Triazolopyridazinové deriváty, způsob jejich výroby a farmaceutický prostředek je obsahující |
| GB9801208D0 (en) | 1998-01-21 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801397D0 (en) | 1998-01-22 | 1998-03-18 | Merck Sharp & Dohme | Therapeutic agents |
| GB9801538D0 (en) | 1998-01-23 | 1998-03-25 | Merck Sharp & Dohme | Pharmaceutical product |
| EP2464645B1 (en) * | 2009-07-27 | 2017-07-05 | Gilead Sciences, Inc. | Fused heterocyclic compounds as ion channel modulators |
| NZ604478A (en) | 2010-07-02 | 2014-12-24 | Gilead Sciences Inc | Fused heterocyclic compounds as ion channel modulators |
| ES2785475T3 (es) | 2011-05-10 | 2020-10-07 | Gilead Sciences Inc | Compuestos heterocíclicos fusionados como moduladores de canales iónicos |
| NO3175985T3 (is) | 2011-07-01 | 2018-04-28 | ||
| UY34171A (es) | 2011-07-01 | 2013-01-31 | Gilead Sciences Inc | Compuestos heterocíclicos fusionados como moduladores del canal iónico |
| PT3548033T (pt) * | 2016-11-28 | 2024-08-09 | Praxis Prec Medicines Inc | Compostos e respectivos métodos de utilização |
| WO2018098491A1 (en) | 2016-11-28 | 2018-05-31 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11492345B2 (en) | 2017-02-13 | 2022-11-08 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| WO2018187480A1 (en) | 2017-04-04 | 2018-10-11 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11278535B2 (en) | 2017-08-15 | 2022-03-22 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| CN117756800A (zh) | 2018-05-30 | 2024-03-26 | 普拉克西斯精密药物股份有限公司 | 离子通道调节剂 |
| US11773099B2 (en) | 2019-05-28 | 2023-10-03 | Praxis Precision Medicines, Inc. | Compounds and their methods of use |
| US11505554B2 (en) | 2019-05-31 | 2022-11-22 | Praxis Precision Medicines, Inc. | Substituted pyridines as ion channel modulators |
| US11279700B2 (en) | 2019-05-31 | 2022-03-22 | Praxis Precision Medicines, Inc. | Ion channel modulators |
| US11767325B2 (en) | 2019-11-26 | 2023-09-26 | Praxis Precision Medicines, Inc. | Substituted [1,2,4]triazolo[4,3-a]pyrazines as ion channel modulators |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1187281A (en) * | 1967-04-10 | 1970-04-08 | Leuna Werke Veb | Process for the Production of Pyridazine Derivatives |
-
1976
- 1976-09-22 US US05/725,597 patent/US4230705A/en not_active Expired - Lifetime
-
1977
- 1977-08-23 ZA ZA00775110A patent/ZA775110B/xx unknown
- 1977-08-23 MW MW21/77A patent/MW2177A1/xx unknown
- 1977-08-30 ZM ZM66/77A patent/ZM6677A1/xx unknown
- 1977-09-01 IS IS2407A patent/IS2407A7/is unknown
- 1977-09-16 PH PH20235A patent/PH13960A/en unknown
- 1977-09-19 MC MC771259A patent/MC1168A1/xx unknown
- 1977-09-21 SU SU772523706A patent/SU793399A3/ru active
- 1977-09-21 SE SE7710595A patent/SE7710595L/xx not_active Application Discontinuation
- 1977-09-22 BE BE181116A patent/BE858949A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA775110B (en) | 1979-03-28 |
| MW2177A1 (en) | 1979-06-13 |
| PH13960A (en) | 1980-11-12 |
| MC1168A1 (fr) | 1978-06-02 |
| SU793399A3 (ru) | 1980-12-30 |
| US4230705A (en) | 1980-10-28 |
| BE858949A (fr) | 1978-03-22 |
| ZM6677A1 (en) | 1979-07-19 |
| SE7710595L (sv) | 1978-05-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2407A7 (is) | Aðferð til þess að framleiða blóðþrýstingslækkandi lyf. | |
| PL195088A1 (pl) | Sposob wytwarzania n-fosfonometyloglicyny | |
| NL170258C (nl) | Capsule. | |
| ES451634A0 (es) | Un metodo de preparar compuestos de alcoxisilano. | |
| NL7706433A (nl) | 4-trifluormethylbenzoezuurderivaten en werkwij- ze voor de bereiding daarvan, alsmede farma- ceutische mengsels, die deze bevatten. | |
| PL199270A1 (pl) | Sposob wytwarzania pochodnych pirazolo(1,5-0)chinazoliny | |
| PL200141A1 (pl) | Srodek owadobojczy,roztoczobojczy i nicieniobojczy oraz sposob wytwarzania n-sulfenylowanych karbaminianow oksymow | |
| DK144912C (da) | Fremgangsmaade til fremstilling af substituerede 2,6-methano-3,4,5,6-tetrahydro-2h-1-benzoxociner | |
| PL198731A1 (pl) | Sposob wytwarzania nowych pochodnych 1-hydroksy-3-alkilodwubenzo/b,d/piranu | |
| SE432099B (sv) | Forfarande for framstellning av 1,4-bensodiazepiner | |
| PL209632A1 (pl) | Sposob wytwarzania 5-podstawionych-10,11-dwuwodoro-5h-dwubenzo(a,d)cykloheptano-5,10-imin | |
| NL7702025A (nl) | Capsule. | |
| NL7606625A (nl) | Koffer, alsmede werkwijze ter vervaardiging ervan. | |
| PL203537A1 (pl) | Sposob wytwarzania n,n-dwupodstawionych chlorowcoacyloamidow | |
| SE7708627L (sv) | Sett att framstella 2,2-dimetyl-19-norsteroider | |
| CS194827B2 (en) | Method of producing 2-chlor-4,6-bis-alkylamino-s-triazines | |
| PL199361A1 (pl) | Sposob wytwarzania 6a,10a-cis-szesciowodorodwubenzopiranonow | |
| BE855271A (fr) | Production de phosphorochlorothionates d'0,0-dialcoyle | |
| SU597676A1 (ru) | Способ получени 2,3,6-триарил-3,4дигидро-2н-1,3-оксазин | |
| DK77177A (da) | Fremgangsmade til fremstilling af 5,6-dehydropencilliner | |
| PL200287A1 (pl) | Sposob wytwarzania 2,5-dwuhydroksybenzenosulfonianow | |
| NL7714583A (nl) | Nieuwe 6,7-dimethoxy- en diethoxy-1,2,3,4-tetra- hydro-1-isochinoline-aceetamidederivaten, werk- wijze ter bereiding daarvan en farmaceutisch preparaten, die deze aceetamidederivaten bevatten. | |
| PL202246A1 (pl) | Sposob wytwarzania 1,1-dwuchlorowco-4-metylopentadienu-1,3 | |
| PL203199A1 (pl) | Sposob wytwarzania ii-rzed.amidow kwasu dwuchlorooctowego | |
| NO770038L (no) | Fremgangsm}te for fremstilling av estere. |